SMEListed
Avience Biomedicals IPO Listing Price, GMP History
Listing results, recorded GMP and issue details
- Reported listing price
- ₹395.2
- Reported listing gain
- +90.00%
- Issue price
- ₹208
- Historical GMP
- ₹145
Recorded grey market premium
GMP return+69.71%+₹145 per share
- Historical listing estimate
- ₹353
- GMP-implied amount per lot
- +₹87,000
- Issue price / upper band
- ₹208
- Total subscription
- 385.4x
IPO dates & allotment schedule
- Offer opens18 Jun 2026
- Offer closes22 Jun 2026
- Scheduled allotment23 Jun 2026
- Scheduled listing25 Jun 2026
Allotment and listing dates are scheduled milestones. Check the registrar for released allotment results; the calendar alone does not confirm release.
Avience Biomedicals IPO details
- Company
- Avience Biomedicals
- Market segment
- SME
- Price band
- ₹196–₹208
- Issue size
- ₹30.24 crore
- Shares per lot
- 600
- Cost of one lot
- ₹1,24,800
- Offer status
- Listed
About Avience Biomedicals and its IPO
Avience Biomedicals is a SME IPO with an issue size of ₹30.24 crore. The offer window was 18 Jun 2026 to 22 Jun 2026. The price band is ₹196–₹208 per share, with 600 shares per lot.
Avience Biomedicals has a reported listing price of ₹395.2 on 25 Jun 2026. Its issue price or upper band was ₹208.
Lot size & investment amounts
| Lots | Shares | Amount | GMP-implied amount |
|---|---|---|---|
| 1 | 600 | ₹1,24,800 | +₹87,000 |
| 2 | 1,200 | ₹2,49,600 | +₹1,74,000 |
| 5 | 3,000 | ₹6,24,000 | +₹4,35,000 |
These are arithmetic examples, not investor-category eligibility limits. Minimum application lots, category limits and discounts must be checked in the offer document.
GMP history
| Recorded | GMP | GMP % | Est. listing |
|---|---|---|---|
| 07 Oct 2026, 21:41 | +₹145 | +69.70% | ₹353 |